Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when LFST files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsLifeStance Health director Teresa DeLuca resigns from board, effective Dec 31
Filed October 16, 2026 · Period ending October 14, 2026 · ~1 min read
Key Changes
-
low
Board member Teresa DeLuca, M.D. notified the company on Oct 14, 2026 that she will resign from the board and all committees, effective Dec 31, 2026.
Item 5.02 verify on EDGAR → -
low
The filing states the resignation is not the result of any disagreement between Dr. DeLuca and the company.
Item 5.02 verify on EDGAR →
Summary
LifeStance Health Group disclosed that board member Teresa DeLuca, M.D. has resigned, effective December 31, 2026. The company stated the resignation is not due to any disagreement, which is a standard disclosure that helps investors rule out a contentious departure.
No replacement or reason beyond the filing's statement was provided. This is a routine governance matter with no immediate red flags.
Section-by-Section Diff
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
On October 14, 2026, Teresa DeLuca, M.D., notified the LifeStance Health Group, Inc. (the “Company”) board of directors (the “Board”) of her resignation from the Board and all of its committees, effective as of December 31, 2026. The resignation is not a result of any disagreement between Dr. DeLuca and the Company.
Dr. DeLuca notified the Board on October 14, 2026 that she is resigning from the Board and all committees, effective December 31, 2026. The filing explicitly states the resignation is not due to any disagreement with the company, which is a standard disclosure that helps investors rule out a contentious departure.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Oct 19, 2026 · How we verify